Dec 01, 2021 05:02 AM

BUSINESS

China’s mRNA Vaccine Developer Abogen Raises $3 Million

By Zhou Xinda, Wang Lijun and Denise Jia

What’s new: Chinese mRNA vaccine developer Suzhou Abogen Biosciences raised $3 million following a $7.2 million C round of financing in August.

The fundraising was led by Softbank Vision Fund and existing investor 5Y Capital. Other investors include Chimera Abu Dhabi, Oriental Fortune Capital, Jinyi Capital, New Frontier Corp., IMO Ventures and South Korean financial services group Mirae Asset Financial Group.

You've accessed an article available only to subscribers

Subscribe today for just $.99.

VIEW OPTIONS

Share this article

Open WeChat and scan the QR code

GALLERY

: Gallery: Asia New Vision Forum Kicks Off in Singapore

NEWSLETTERS

Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription

PODCAST

Caixin Deep Dive: Former Securities Regulator Yi Huiman’s Corruption Probe

00:00

00:00/00:00

MOST POPULAR

1: Finance Movers and Shakers: Former Securities Watchdog Chief Yi Huiman Under Graft Probe

2: Hong Kong Moves to Ease Capital Rules for Banks Holding Licensed Crypto

3: AI Offers Hope for Growth, but Global ‘Disorder’ Poses Major Risks, Lawrence Summers Says

4: China’s Regulator Ramps Up Push to Curb Food Delivery Subsidy War

5: China, U.S. to Meet in Spain Over TikTok, Trade Disputes

SPONSORED

OR